BioWorld MedTech

Jan. 23, 2013

Selventa focuses on developing personalized care diagnostics

Selventa (Cambridge, Massachusetts) reported that it plans to introduce a new class of diagnostic test that would promote personalized healthcare technologies. Read More

Welch Allyn gains FDA clearance for iExaminer

Report from Europe: EU urged to act quickly on key med-tech regulations

Washington roundup: Covering OCT for verteporfin helps docs, not device makers

Financings roundup: MRI Interventions enters into securities purchase agreement

Agreements/contracts: Xifin uses PAML account management platforms

Deals roundup: Aetna in plan to sell Missouri Care to WHP

HIT roundup: New Mexico HIE to use Orion platform statewide

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 26, 2026.

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026